Clinical Trial: A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists

U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT06834009) titled 'A Study of Suzetrigine (SUZ) Spray-dried Dispersion (SSD) in Healthy Adult Panelists' on Feb. 13.

Brief Summary: The purpose of this study is to evaluate the sensory attributes (basic tastes, aroma, texture, mouthfeel) of SUZ SDD and assess the impact of the dose on the sensory attributes.

Study Start Date: March 10

Study Type: INTERVENTIONAL

Condition: Pain

Intervention: DRUG: SUZ

Powder for oral administration.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Vertex Pharmaceuticals Incorporated

Published by HT Digital Content Services with permission from Health Daily Digest....